ApoB x LDL-C/ApoA1 x HDL-C: A new predictor of coronary risk

被引：0
|
作者：
Izar, M. C. O. [1 ]
Pinto, L. D. E. S. A. [1 ]
Lopes, I. E. L. [1 ]
Fischer, S. C. P. M. [1 ]
Fonseca, M. I. H. [1 ]
Lhara, S. S. M. [1 ]
Kasinski, N. [1 ]
Fonseca, F. A. H. [1 ]
机构：
[1] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(07)71969-4
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [31] Association of LDL-C/HDL-C ratio with coronary heart disease: A meta-analysis
    Hu, Siqi
    Fan, Hua
    Zhang, Shenghui
    Chen, Chen
    You, Yao
    Wang, Chunyi
    Li, Jie
    Luo, Lin
    Cheng, Yongran
    Zhou, Mengyun
    Zhao, Xuezhi
    Wen, Wen
    Tan, Tao
    Xu, Fangfang
    Fu, Xinyan
    Chen, Juan
    Zhang, Xingwei
    Wang, Mingwei
    Tang, Jiake
    INDIAN HEART JOURNAL, 2024, 76 (02) : 79 - 85
  • [32] Oxidative modifications of foetal LDL-c and HDL-c lipoproteins in preeclampsia
    G. León-Reyes
    S. Espino y Sosa
    R. Medina-Navarro
    A. M. Guzmán-Grenfell
    A. X. Medina-Urrutia
    S. Fuentes-García
    G. J. J. Hicks
    Y. D. Torres-Ramos
    Lipids in Health and Disease, 17
  • [33] HDL-C and LDL-C: Their role in stroke pathogenesis and implications for treatment
    Sanossian N.
    Tarlov N.E.
    Current Treatment Options in Cardiovascular Medicine, 2008, 10 (3) : 195 - 206
  • [34] Oxidative modifications of foetal LDL-c and HDL-c lipoproteins in preeclampsia
    Leon-Reyes, G.
    Espino y Sosa, S.
    Medina-Navarro, R.
    Guzman-Grenfell, A. M.
    Medina-Urrutia, A. X.
    Fuentes-Garcia, S.
    Hicks, G. J. J.
    Torres-Ramos, Y. D.
    LIPIDS IN HEALTH AND DISEASE, 2018, 17
  • [35] Managing diabetic dyslipidaemia - beyond LDL-C: HDL-C and triglycerides
    Barter, Philip
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (04) : 17 - 21
  • [36] Effect of statin treatment on LDL-C/HDL-C goal attainment
    Crouse, JR
    Alexander, CM
    Weiss, TW
    Lu, JD
    Lattin, GM
    Krantzler, JD
    Markson, LE
    CIRCULATION, 2001, 104 (17) : 829 - 829
  • [37] The clinical utility of apoB versus LDL-C/non-HDL-C
    Kohli-Lynch, Ciaran N.
    Thanassoulis, George
    Moran, Andrew E.
    Sniderman, Allan D.
    CLINICA CHIMICA ACTA, 2020, 508 : 103 - 108
  • [38] Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c
    Hajer, G. R.
    van der Graaf, Y.
    Bots, M. L.
    Algra, A.
    Visseren, F. L. J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (08) : 680 - 688
  • [39] ApoA1/HDL-C ratio as a predictor for coronary artery disease in patients with type 2 diabetes: a matched case-control study
    Ghaemi, Farzaneh
    Rabizadeh, Soghra
    Yadegar, Amirhossein
    Mohammadi, Fatemeh
    Asadigandomani, Hassan
    Bafrani, Melika Arab
    Reyhan, Sahar Karimpour
    Esteghamati, Alireza
    Nakhjavani, Manouchehr
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [40] Serum TC/HDL-C,TG/HDL-C and LDL-C/HDL-C in predicting the risk of myocardial infarction in normolipidaemic patients in South Asia:A case-control study
    Arun Kumar
    Ramiah Sivakanesan
    Asian Pacific Journal of Tropical Medicine, 2008, 1 (02) : 21 - 27
12345